The protective properties of vaccination against equine herpesvirus 1-induced viremia, abortion and nervous system disorders

Vlaams Diergeneeskundig Tijdschrift

Volumn 76, Issue 3, 2007, Pages 186-194

  Van Der Meulen, K M ^a   Gryspeerdt, A C ^a   Vandekerckhove, A A ^a   Garre B A ^a   Nauwynck, H J ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EQUID HERPESVIRUS 1; EQUIDAE; HUMAN HERPESVIRUS 1;

EID: 34547519741     PISSN: 03039021     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Allen G.P., Bryans J.T. (1986). Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections. Progress in Veterinary Microbiology and Immunology 2, 78-144.
2. Becker W (1988). Preventive vaccination against EHV (equine herpesvirus) abortion. Tierärztliche Praxis 16, 61-63.
3. Bentz B.G., Maxwell L.K., Erkert R.S., Royer CM., Davis M.S., MacAllister C.G., Clarke C.R. (2006). Pharmacokinetics of acyclovir after single intravenous and oral administration to adult horses. Journal of Veterinary Internal Medicine 20, 589-594.
4. Bryans J.T., Allen G.P. (1982). Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I. Developments in Biological Standardization 52, 493-498.
5. Bürki F., Rossmanith W., Nowotny N., Pallan C., Möstl K., Lussy H. (1990). Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses. Veterinary Quarterly 12, 80-86.
6. Burrows R., Goodridge D., Denyer M.S. (1984). Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus. The Veterinary Record 114, 369-374.
7. Cook R.F., O'Neill T., Strachan E., Sundquist B., Mumford J.A. (1990). Protection against lethal equine herpes virus type 1 (subtype 1) infection in hamsters by immune stimulatingcomplexes (ISCOMs) containing the major viral glycoproteins. Vaccine 8, 491-496.
8. Crowhurst F.A., Dickinson G, Burrows R. (1981). An outbreak of paresis in mares and geldings associated with equidherpesvirus 1. The Veterinary Record 109, 527-528.
9. Csellner H., Walker C., Wellington J.E., McLure L.E., Love D.N., Whalley J.M. (2000). EHV-1 glycoprotein D (EHV-1gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice. Archives of Virology 145, 2371-2385.
10. Edington N., Bridges C.G., Patel J.R. (1986). Endothelial cell infection and thrombosis in paralysis caused by equid herpesvirus-1: equine stroke. Archives of Virology 90, 111-124.
11. Edington N., Smyth B., Griffiths L. (1991). The role of endothelial cell infection in the endometrium, placenta and foetus of equid herpesvirus 1 (EHV-1) abortions. Journal of Comparative Pathology 104, 379-387.
12. Foote C.E., Raidal S.L., Pecenpetelovska G, Wellington J.E., Whalley J.M. (2006). Inoculation of mares and very young foals with EHV-1 glycoproteins D and B reduces virus shedding following respiratory challenge with EHV-1. Veterinary Immunology Immunopathology 111, 97-108.
13. Frymus T., Kita J., Woyciechowska S., Ganowicz M. (1986). Foetal and neonatal foal losses on equine herpesvirus type 1 (EHV-1) infected farms before and after EHV-1 vaccination was introduced. Polskie Archiwum Weterynaryjne 26, 7-14.
14. GarréB., van der Meulen K.M., De Backer P., Nauwynck H.J., Croubels S. (2006). In vitro efficacy of acyclovir against equine herpesvirus-1 and pharmacokinetics of acyclovir in aádthacses. Journal of Veterinary Pharmacology and Therapeutics 29 (suppl. 1), 223-224.
15. Garré B., van der Meulen K.M., Neyts J., Croubels S., De Backer P., Nauwynck H. (2007). In vitro susceptibility of 6 strains of equine herpes virus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet. Veterinary Microbiology, doi: 10.1016/j.vetmic.2007.01.004.
16. Gibson J.S., Slater J.D., Awan A.R., Field H.J. (1992). Pathogenesis of equine herpesvirus-1 in specific pathogen-free foals: primary and secondary infections and reactivation. Archives of Virology 123, 351-366.
17. Goodman L.B., Wagner B., Flaminio MJ., Sussman K.H., Metzger S.M., Holland R., Osterrieder N. (2006). Comparison of the efficacy of inactivated combination and modified-live virus vaccines against challenge infection with neuropathogenic equine herpesvirus type 1 (EHV-1). Vaccine 24, 3636-3645.
18. Hannant D., Jessett D.M., O'Neill T., Dolby CA., Cook R.F., Mumford J.A. (1993). Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain. Research in Veterinary Science 54, 299-305.
19. Hassett D.E., Whitton J.L. (1996). DNAimmunization. Trends in Microbiology 4, 307-312.
20. 1,4). Vaccination/ challenge experiments in foals and pregnantmares. Vaccine 19, 4307-4317.
21. Jackson T. A., Osburn B.I., Cordy D.R., Kendrick J.W. (1977). Equine herpesvirus 1 infection of horses: studies on the experimentally induced neurologic disease. American Journal of Veterinary Research 38, 709-719.
22. Kydd J.H., Smith K.C., Hannant D., Livesay G.J., Mumford J.A. (1994a). Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract of ponies: implications for vaccination strategies. Equine Veterinary Journal 26, 466-469.
23. Kydd J.H., Smith K.C., Hannant D., Livesay G.J., Mumford J. A. (1994b). Distribution of equid herpesvirus-1 (EHV-1) in respiratory tract associated lymphoid tissue: implications for cellular yrsmaraty. Equine Veterinary Journal 26, 470-473.
24. Kukreja A., Walker C., Fitzmaurice T., Awan A., Love D.N., Whalley J.M., Field H.J. (1998). Protective effects of equine herpesvirus-1 (EHV-1) glycoprotein B in a murine model of EHV-1-induced abortion. Veterinary Microbiology 62, 303-311.
25. Learmonth G.S., Love D.N., Gilkerson J.R., Wellington J.E., Whalley J.M. (2003). Inoculation with DNA encoding the glycoprotein gp2 reduces severity of equine herpesvirus 1 infection in a mouse respiratory model. Archives of Virology 148, 1805-1813.
26. Matsumura T., O'Callaghan D.J., Kondo T., Kamada M. (1996). Lack of virulence of the murine fibroblast adapted strain, Kentucky A (KyA), of equine herpesvirus type 1 (EHV-1) in young horses. Veterinary Microbiology 48, 353-365.
27. Matsumura T., Kondo T., Sugita S., Damiani A.M., O'Callaghan DJ., Imagawa H. (1998). An equine herpesvirus type 1 recombinant with a deletion in the gE and gl genes is avirulent in young horses. Virology 242, 68-79.
28. McCartan C.G., Russell M.M., Wood J.L.N., Mumford J.A. (1995). Clinical, serological and virological characteristics of an outbreak of paresis and neonatal foal disease due to equine herpesvirus-1 on a stud farm. The Veterinary Record 136, 7-12.
29. Minke J.M., Fischer L., Baudu P., Guigal P.M., Sindle T., Mumford J.A., Audonnet J.C (2006). Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Veterinary Immunology Immunopathology 111, 47-57.
30. Mumford J.A., Hannant D., Jessett D.M., O'Neill T., Smith K.C., Ostlund E.N. (1994). Abortigenic and neurological disease caused by experimental infection with equid herpesvirus-1. In: Proceedings of the Seventh International Conference of Equine Infectious Diseases. Tokyo, Japan, pp. 261-275.
31. Neubauer Á., Braun B., Brandmuller C, Kaaden O.R., OsterriederN. (1997). Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. Virology 227, 281-294.
32. Osterrieder N. (1999). Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant. Virus Research 59, 165-177.
33. Paillot R., Ellis S.A., Daly J.M., Audonnet J.C, Minke J.M., Davis-Poynter N., Hannant D., Kydd J.H. (2006). Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with aNYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Vaccine 24, 1490-1500.
34. Patel J.R., Edington N., Mumford J.A. (1982). Variation in cellular tropism between isolates of equine herpesvirus-1 in foals. Archives of Virology 74, 41-54.
35. Patel J.R., Bateman H., Williams J., Didlick S. (2003a). Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1. Veterinary Microbiology 91, 23-39.
36. Patel J.R., Foldi J., Bateman H., Williams J., Didlick S., Stark R. (2003b). Equid herpesvirus (EHV-1) live vaccine strain C147 : efficacy against respiratory diseases following EHV types 1 and 4 challenges. Veterinary Microbiology 92, 1-17.
37. Perdue M.L., Kemp M.C., Randall C.C., O'Callaghan D.J. (1974). Studies of the molecular anatomy of the L-M cell strain of equine herpes virus type 1 : proteins of the nucleocapsid and intact virion. Virology 59, 201-216.
38. Randall CC, Lawson L.A. (1962). Adaptation of equine abortion virus to Earle's L-cells in serum-free medium with plaque formation. Proceedings of the Society for Experimental Biology and Medicine 110, 487-489.
39. Ruitenberg K.M., Walker C., Wellington J.E., Love D.N., Whalley J.M. (1999). DNA-mediated immunization with glycoprotein D of equine herpesvirus 1 (EHV-1) in a murine model ofEHV-1 respiratory infection. Vaccine 17, 237-244.
40. Slater J.D., Gibson J.S., Field H.J. (1993). Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals. Journal of General Virology 74, 819-828.
41. Smith K.C., Whitwell K.E., Binns M.M., Dolby CA., Hannant D., Mumford J.A. (1992). Abortion of virologically negative foetuses following experimental challenge of pregnant pony mares with equid herpesvirus 1. Equine Veterinary Journal 24, 256-259.
42. Smith K.C., Whitwell K.E., Mumford J.A., Gower S.M., Hannant D.,Tearle J.P. (1993). An immunohistological study of the uterus of mares following experimental infection by equid herpesvirus 1. Equine Veterinary Journal 25, 36-40.
43. Smith K.C., Borchers K. (2001). A study of the pathogenesis of equid herpesvirus-1 (EHV-1) abortion by DNA in-situ hybridization. Journal of Comparative Pathology 125, 304-310.
44. Soboll G., Hussey S.B., Whalleyt J.M., Allen G.P., Koen M.T., Santucci N., Fraser D.G., Maclin M.D., Swain W.R., Lunn D.P. (2006). Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies. Veterinary Immunology Immunopathology 111, 81-95.
45. Tewari D., Gibson J.S., Slater J.D., O'Neill T., Hannant D., Allen G.P., Field H.J. (1993). Modulation of the serological response of specific pathogen-free (EHV-free) foals to EHV-1 by previous infection with EHV-4 or a TK-deletion mutant of EHV-1. Archives of Virology 132, 101-120.
46. Tewari D., Nair S.V., DeUngria M.C., Lawrence G.L.,Hayden M., Love D.N., Field HJ., Whalley J.M. (1995). Immunization with glycoprotein C of equine herpesvirus-1 is associated with accelerated virus clearance in a murine model. Archives of Virology 140, 789-797.
47. TheinR, Brown K. (1988). Infection mit equinen Herpesviren und Manifestation am Zentralnervensystem beim Pferd. Tierärztliche Praxis 16, 295-302.
48. Tsujimura K.,Yarnanaka T., Kondo T., Fukushi H., MatsumuraT. (2006). Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models. Journal of Veterinary Medical Science 68, 1029-1038.
49. von Benten C. Petzoldt K. (1977). Several years of diagnostic studies on the EHV1 abortion in thoroughbred studs following the introduction of vaccination. Berliner und Münchener Tierärztliche Wochenschrift 90, 176-180.
50. Weerasinghe C.U., Learmonth G.S., Gilkerson J.R., Foote C.E., Wellington J.E., Whalley J.M. (2006). Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse. Veterinary Immunology Immunopathology 111, 59-66.
51. Wilkins P.A., Papich M., Sweeney R. W. (2005). Pharmacokinetics of acyclovir in adult horses. Journal of Veterinary Emergency and Critical Care 15, 174-178.
52. Woyciechowska S. (1960). Adaptation of equine abortion virus (isolated in Poland) strain RAC-Heraldia to Syrian hamster. Medycyna Doswiadczalna i Mikrobiologia 12, 255-263.
53. Woyciechowska S., Kita J., Frymus T., Górski J., Michalak T., Chmielewska A. (1980). A vaccine against rhinopneumonitis equorum - studies of safety and immunogeniciry in pregnant mares. Medycyna Weterynaryjne 36, 525-529.